Biotech

All Articles

AC Immune views 'spots' possible in Alzheimer's medication records

.After greater than 20 years of work on neurodegenerative ailments, Swiss biotech air conditioner In...

GSK loses ph. 2 HPV vaccination over absence of best-in-class possible

.GSK has broken up a stage 2 human papillomavirus (HPV) injection coming from its own pipeline after...

OS Treatments refiles $6M IPO to cash HER2 drug, preclinical ADCs

.Operating system Therapies will certainly detail on the NYSE American supply substitution this morn...

ALX's waning CD47 feedback fee sends out sell spiraling down

.ALX Oncology's phase 2 stomach cancer cells action cost has actually weakened. After seeing its own...

Ionis axes eye health condition coming from targets of Roche-partnered possibility after information let down

.An Additional of Ionis Pharmaceuticals' vital midphase readouts has disappointed assumptions, trigg...

Biogen's CEO pointed out no dangerous handle 2023. He's ready to be bold

.While Biogen's pharma peers are actually seeking for late-stage possessions along with little threa...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Bio has been actually a biotech seeking a pipe after it scrapped its own lead possessions ov...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned legal rights to a very early Alzheimer's condition course to Denali Re...

Takeda touches new head of US oncology organization-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Vertex, beaten by AATD again, goes down 2 properties on discard heap

.Tip's attempt to treat a rare hereditary disease has reached one more problem. The biotech threw tw...